Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × INDUSTRY × PM 01183 × Clear all

Phase

Status

Completed 18 Recruiting 5 Not yet recruiting 2 Active not recruiting 2 Terminated 1 Approved for marketing 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

pembrolizumab 153 Paclitaxel 107 Carboplatin 106 Gemcitabine 99 Docetaxel 87 Cyclophosphamide 82 Nivolumab 73 Cisplatin 70 Rituximab 63 Bevacizumab 56 Dexamethasone 53 Capecitabine 51 Pemetrexed 49 fludarabine 47 Fluorouracil 44 Azacitidine 42 venetoclax 40 atezolizumab 40 Irinotecan 35 Trastuzumab 34 Leucovorin 32 130-nm albumin-bound paclitaxel 32 Cetuximab 31 Cytarabine 30 Erlotinib Hydrochloride 29 avelumab 27 Fulvestrant 27 Prednisone 26 Oxaliplatin 26 Ipilimumab 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05126433 2025-02-28

JAZZ EMERGE201

Jazz Pharmaceuticals

Phase 2 Terminated

47 enrolled 16 charts

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡